Health Mainz Biomed Announces Live Launch of ColoAlert® with Globe News Wire Aug 1, 2023 BERKELEY, Calif. and MAINZ, Germany, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced…
Health Mainz Biomed Expands Corporate Health Program for ColoAlert Globe News Wire Apr 4, 2023 BERKELEY, Calif. and MAINZ, Germany, April 04, 2023 (GLOBE…